Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 15 8:43 PM | ELIZABETH REED | Proposed Sale | 39,576 | $65.79 | $2.6M | — | View → |
| Sep 15, 2026 | Sep 15 8:42 PM | ERIC DUBE | Proposed Sale | 95,666 | $65.79 | $6.3M | — | View → |
| Sep 15, 2026 | Sep 15 8:41 PM | PETER HEERMA | Proposed Sale | 102,190 | $65.79 | $6.7M | — | View → |
| Sep 15, 2026 | Sep 15 8:35 PM | WILLIAM ROTE | Proposed Sale | 96,198 | $65.79 | $6.3M | — | View → |
| Sep 15, 2026 | Sep 15 8:24 PM | JULA INRIG | Proposed Sale | 44,674 | $65.79 | $2.9M | — | View → |
| Sep 10, 2026 | Sep 11 8:05 PM | Meckler Jeffrey ADirector | Sale | 20,000 | $67.31 | $1.3M | 91,500(D) | View → |
| Sep 10, 2026 | Sep 10 8:38 PM | JEFFREY MECKLER | Proposed Sale | 20,000 | $66.22 | $1.3M | — | View → |
| Sep 2, 2026 | Sep 3 8:05 PM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 642 | $66.37 | $42.6K | 118,016(D) | View → |
| Aug 18, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Sale | 5,000 | $63.37 | $316.9K | 61,500(D) | View → |
| Aug 17, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Sale | 5,000 | $63.20 | $316.0K | 61,500(D) | View → |
| Aug 18, 2026 | Aug 18 8:24 PM | GARY LYONS | Proposed Sale | 5,000 | $63.53 | $317.6K | — | View → |
| Aug 17, 2026 | Aug 17 8:31 PM | GARY A LYONS | Proposed Sale | 5,000 | $62.14 | $310.7K | — | View → |
| Jun 12, 2026 | Jun 16 8:46 PM | Timothy CoughlinDirector | Sale | 10,000 | $50.07 | $500.7K | 56,250(D) | View → |
| Jun 12, 2026 | Jun 16 8:42 PM | Roy D. BaynesDirector | Sale | 4,500 | $50.00 | $225.0K | 41,500(D) | View → |
| Jun 12, 2026 | Jun 12 8:05 PM | ROY BAYNES | Proposed Sale | 4,500 | $50.00 | $225.0K | — | View → |
| Jun 12, 2026 | Jun 12 4:20 PM | Coughlin Timothy | Proposed Sale | 10,000 | $50.04 | $500.4K | — | View → |
| May 15, 2026 | May 19 8:05 PM | Timothy CoughlinDirector | Sale | 3,250 | $43.49 | $141.3K | 52,250(D) | View → |
| May 15, 2026 | May 15 4:51 PM | Coughlin Timothy | Proposed Sale | 3,250 | $43.44 | $141.2K | — | View → |
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Sale | 4,500 | $46.65 | $209.9K | 37,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Sale | 8,000 | $45.00 | $360.0K | 87,500(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21 9:00 PM | John A OrwinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Meckler Jeffrey ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | LYONS GARY ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Timothy CoughlinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Suzanne Louise BruhnDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Roy D. BaynesDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Option Exercise | 4,500 | $18.27 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 24,250 | $17.96 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Option Exercise | 24,250 | $22.40 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |